Related Experiment Videos
[The hyperactive child: diagnosis and therapy].
1Zentrum für Kinder- und Jugendpsychiatrie Zürich, Universität Zürich. steinh@kjpd.unizh.ch
Praxis
|July 14, 2001
Summary
This study outlines the clinical assessment of childhood hyperkinetic disorder, emphasizing neurobiological and genetic factors. Treatment is multimodal, often including stimulant pharmacotherapy.
Area of Science:
- Childhood Neurodevelopmental Disorders
- Pediatric Psychiatry
Context:
- Hyperkinetic disorder (HKD) in childhood presents complex diagnostic challenges.
- Accurate assessment is crucial for effective intervention and management.
Purpose:
- To detail the comprehensive clinical assessment process for childhood hyperkinetic disorder.
- To highlight the importance of differential diagnosis and neurobiological etiological factors.
- To discuss current multimodal treatment strategies, including pharmacotherapy.
Summary:
- Clinical assessment involves psychiatric interviews, developmental history, standardized rating scales, neuropsychological testing, and physical examination.
- Differential diagnosis is essential to rule out other conditions and ensure accurate HKD diagnosis.
- Etiology is primarily understood through neurobiological frameworks, with a significant genetic component.
- Treatment is multimodal, integrating behavioral interventions with pharmacotherapy, particularly stimulants.
Impact:
- Provides a framework for standardized and accurate diagnosis of childhood hyperkinetic disorder.
- Informs clinical practice regarding evidence-based assessment and treatment approaches.
- Contributes to understanding the neurobiological underpinnings and genetic influences of HKD.